⌘K

Home/Insiders/Scott Kathleen D.

SK

SEC Insider//CIK 0001794284

Scott Kathleen D.

CIK 00017942843 companiesSANTA ANA, CA

Transactions

11

Companies

3

Filings

6

CIK

0001794284

Recent Transactions

11 trades

Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-12-06+500,000→ 500,000 total
Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-12-06+300,000→ 300,000 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-10-16−12,500→ 802,330 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-16$1.50/sh+12,500→ 17,449 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-16$16.00/sh−12,500→ 4,949 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$16.00/sh−12,500→ 13,199 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$1.50/sh+12,500→ 25,699 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-08-20−12,500→ 814,830 total
Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-02-12+300,000→ 300,000 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (Right to Buy)
2024-01-04+10,000→ 10,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2024-01-02+200,000→ 200,000 total

Companies

3

Recent Filings

6

Address

NKGEN BIOTECH, INC. 3001 DAIMLER STREET

SANTA ANA, CA, 92705

View on SEC.gov